Figure 2From: TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseasesNumber of cytogenetic abnormalities with respect to TP53 mutation in therapy-related myeloid neoplasm (A) and in de novo myelodysplastic syndromes/acute myeloid leukemia (MDS/AML) (B). TP53 mut, cases with TP53 mutation; TP53 wt, cases with wild-type TP53.Back to article page